Smaller Size – 25% smaller and 24% lighter than the previous generation of BTE processor, the Nucleus 6 (CP 900 series).Compatibility – The N7 is now compatible with all generations of implants including the Nucleus 22 implant.In this article we’ll focus on the key features of the N7 processor but we’ll also discuss some of the difference between the N7 and the Kanso 2. Either processor style is appropriate both for adults and children depending on the cosmetic and lifestyle preferences of the wearer as well as retention and technology and medical considerations. in 2017 as well as their new Kanso® 2 off-the-ear (OTE) style introduced in the U.S. Nucleus 7 (aka N7 or CP1000) sound processors and headpieces from Cochlear Ltd.Ĭochlear currently offers two wearing styles for their speech processors including the N7 BTE style introduced in the U.S. The company also refers to N7 as the “CP 1000” in its literature. The Nucleus® 7 (N7) sound processor is the current behind-the-ear (BTE) sound processor from Cochlear replacing the previous Nucleus 6 (N6) processor. However, the external processors are continually improved upon by manufacturers frequently delivering enhancements for the wearer.
The internal implant is rarely replaced and is expected to last for multiple decades-often for the life of the recipient. Cochlear currently enjoys the dominant cochlear implant market share in the U.S.Ĭochlear implants from every manufacturer require two separate components-the internal implant itself which is surgically implanted and the external speech processor. Today they provide a range of implantable solutions including osseointegrated (bone-integrated) implants, acoustic implants, and cochlear implants. Cochlear was the first company to be approved in the United States for their multi-channel cochlear implant in 1984. is a global company headquartered in Australia, and one of the pioneers in the field of cochlear implants.
0 kommentar(er)
